Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Scottish HTA Body OKs Novartis’ Aimovig For Migraine And Eisai’s Lenvima For Cancer
Apr 10 2019
•
By
Francesca Bruce
Scotland's HTA Recommends Novartis' Migraine Treatment Aimovig • Source: Shutterstock
More from Europe
More from Geography